Likewise, high-grade BLCA patients had higher gene expression levels of FAT4 and lower gene expression levels of RPL37P1, further corroborating that FAT4 gene was positively correlated with the degree of BLCA malignancy and RPL37P1 gene was protective (Figure 5B). The gene discussed is FAT4; the disease is bladder transitional cell carcinoma.